Use este identificador para citar ou linkar para este item: http://repositorio.ufc.br/handle/riufc/27991
Tipo: Artigo de Periódico
Título: Anti-inflammatory and anti-nociceptive effects of strontium ranelate on the zymosan-induced temporomandibular joint inflammatory hypernociception in rats depend on TNF- a inhibition
Autor(es): Alves, Sheila Moreira
Abreu, Susana Capistrano
Lemos, Jonas Cavalcante
Gomes, Francisco Isaac Fernandes
Alves, Shirley Moreira
Val, Danielle Rocha do
Freitas, Raul Sousa
Pereira, Karuza Maria Alves
Pinto, Vicente de Paulo Teixeira
Brito, Gerly Anne de Castro
Bezerra, Mirna Marques
Cristino-Filho, Gerardo
Chaves, Hellíada Vasconcelos
Palavras-chave: Artrite;Arthritis;Estrôncio
Data do documento: Ago-2017
Instituição/Editor/Publicador: Pharmacological Reports
Citação: ALVES, S. M. et al. Anti-inflammatory and anti-nociceptive effects of strontium ranelate on the zymosan-induced temporomandibular joint inflammatory hypernociception in rats depend on TNF-α inhibition. Pharmacological Reports, Krakow, v. 69, n. 4, p. 764-772, aug. 2017.
Abstract: Background Temporomandibular joint (TMJ) disorders show inflammatory components, heavily impacting on quality of life. Strontium ranelate has previously shown anti-inflammatory and antinociceptive effects on other experimental inflammatory pain models. Thus, we aim to investigate the strontium ranelate efficacy in reducing the zymosan-induced inflammatory hypernociception in the TMJ of rats by evaluating the TNF-α, IL-1β, and hemeoxygenase-1 (HO-1) involvement. Methods Wistar rats were treated with strontium ranelate (0.5, 5 or 50 mg/kg, per os) 1 h before zymosan injection (iart). Mechanical threshold was assessed by Von Frey test and synovial lavage was collected for leukocyte counting and myeloperoxidase measurement, joint tissue and trigeminal ganglion were excised for histopathological analysis (H&E) and TNF-α/IL-1β levels dosage (ELISA). Moreover, rats were pre-treated with ZnPP-IX (3 mg/kg, sc), a specific HO-1 inhibitor, before strontium ranelate administration (0.5 mg/kg, per os), and Evans Blue (5 mg/kg, iv) was administered to assess plasma extravasation. Pre-treatment with indomethacin (5 mg/kg, sc) was used as positive control while the sham group received 0.9% sterile saline (per os and iart). Results Strontium ranelate did not reduce leukocyte counting, myeloperoxidase activity, Evans Blue extravasation, IL-1β levels, and TNF-α/IL-1β immunolabeling; but it increased the nociceptive threshold and reduced TNF-α levels. Additionally, HO-1 inhibition did not change the strontium ranelate effects. Conclusion Strontium ranelate may achieve its antinociceptive effects through the reduction of TNF-α levels in the trigeminal ganglion, but not suppressing IL-1β expression nor inducing the HO-1 pathway.
URI: http://www.repositorio.ufc.br/handle/riufc/27991
ISSN: 1734-1140
Aparece nas coleções:PPGF - Artigos publicados em revistas científica

Arquivos associados a este item:
Arquivo Descrição TamanhoFormato 
2017_art_smalves.pdf2,69 MBAdobe PDFVisualizar/Abrir


Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.